AnaptysBio (ANAB)
(Delayed Data from NSDQ)
$21.00 USD
+2.13 (11.29%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $20.99 -0.01 (-0.05%) 6:20 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for AnaptysBio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -163.62 | -128.72 | -57.80 | -19.93 | -97.34 |
Depreciation/Amortization & Depletion | -8.15 | -0.17 | 2.58 | 1.02 | 0.51 |
Net Change from Assets/Liabilities | -0.32 | 6.84 | -7.49 | -6.77 | 16.85 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 51.29 | 48.46 | 16.78 | 11.53 | 10.45 |
Net Cash From Operating Activities | -120.80 | -73.59 | -45.92 | -14.16 | -69.52 |
Property & Equipment | -0.81 | -0.36 | -1.35 | -0.57 | -0.81 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 145.56 | -394.49 | 40.19 | 95.04 | 132.24 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 144.75 | -394.85 | 38.84 | 94.48 | 131.43 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -47.53 | 11.83 | 2.55 | 0.50 | 3.01 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -1.38 | -7.50 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -11.77 | 32.19 | 249.75 | 0.00 | 0.00 |
Net Cash from Financing Activities | -59.30 | 44.02 | 252.30 | -0.88 | -4.49 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -35.34 | -424.42 | 245.21 | 79.44 | 57.42 |
Cash at Beginning of Period | 71.31 | 495.73 | 250.52 | 171.08 | 113.66 |
Cash at End of Period | 35.97 | 71.31 | 495.73 | 250.52 | 171.08 |
Diluted Net EPS | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 |
Fiscal Year End for AnaptysBio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -163.62 | -121.41 | -84.10 | -44.26 |
Depreciation/Amortization & Depletion | NA | -8.15 | -5.60 | -3.19 | -1.60 |
Net Change from Assets/Liabilities | NA | -0.32 | 2.33 | 11.34 | 8.09 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 51.29 | 38.22 | 25.98 | 13.20 |
Net Cash From Operating Activities | NA | -120.80 | -86.45 | -49.98 | -24.57 |
Property & Equipment | NA | -0.81 | -0.53 | -0.37 | -0.18 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 145.56 | 96.10 | 65.31 | 85.57 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 144.75 | 95.58 | 64.94 | 85.40 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -47.53 | -47.79 | -47.95 | -36.26 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -11.77 | -6.35 | -3.11 | -1.31 |
Net Cash from Financing Activities | NA | -59.30 | -54.14 | -51.07 | -37.57 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -35.34 | -45.01 | -36.10 | 23.25 |
Cash at Beginning of Period | NA | 71.31 | 71.31 | 71.31 | 71.31 |
Cash at End of Period | NA | 35.97 | 26.30 | 35.21 | 94.56 |
Diluted Net EPS | NA | -1.59 | -1.41 | -1.50 | -1.58 |